Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Arthritis Research & Therapy
|
December 29, 2012
T cells in myositis
Vivianne Malmström, Paulius Venalis, Inka Albrecht
Immunology
|
April 26, 2002
Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo
Alexander H Dalpke, Stefan Zimmermann, Inka Albrecht, et al.
European Journal of Immunology
|
July 4, 2014
Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion
Jessica Herrath, Karine Chemin, Inka Albrecht, et al.
EMBO Reports
|
January 30, 2004
Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter
Inka Albrecht, Thomas Tapmeier, Stefan Zimmermann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 8, 2025
Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN)
Ralph von Kiedrowski, Martin Metz, Elke Weisshaar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 7, 2016
Reply
Karine Chemin, Inka Albrecht, Sabrina Pollastro, et al.
Immunity
|
May 12, 2009
Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow
Koji Tokoyoda, Sandra Zehentmeier, Ahmed N Hegazy, et al.
European Journal of Immunology
|
November 10, 2010
IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells
Maria H Lexberg, Annegret Taubner, Inka Albrecht, et al.
European Journal of Immunology
|
October 1, 2008
Th memory for interleukin-17 expression is stable in vivo
Maria H Lexberg, Annegret Taubner, Anna Förster, et al.
Rheumatology Advances in Practice
|
February 11, 2022
Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
Hans-Peter Tony, Eugen Feist, Peer Malte Aries, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Arthritis Research & Therapy
|
December 29, 2012
T cells in myositis
Vivianne Malmström, Paulius Venalis, Inka Albrecht
Immunology
|
April 26, 2002
Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo
Alexander H Dalpke, Stefan Zimmermann, Inka Albrecht, et al.
European Journal of Immunology
|
July 4, 2014
Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion
Jessica Herrath, Karine Chemin, Inka Albrecht, et al.
EMBO Reports
|
January 30, 2004
Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter
Inka Albrecht, Thomas Tapmeier, Stefan Zimmermann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 8, 2025
Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN)
Ralph von Kiedrowski, Martin Metz, Elke Weisshaar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 7, 2016
Reply
Karine Chemin, Inka Albrecht, Sabrina Pollastro, et al.
Immunity
|
May 12, 2009
Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow
Koji Tokoyoda, Sandra Zehentmeier, Ahmed N Hegazy, et al.
European Journal of Immunology
|
November 10, 2010
IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells
Maria H Lexberg, Annegret Taubner, Inka Albrecht, et al.
European Journal of Immunology
|
October 1, 2008
Th memory for interleukin-17 expression is stable in vivo
Maria H Lexberg, Annegret Taubner, Anna Förster, et al.
Rheumatology Advances in Practice
|
February 11, 2022
Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
Hans-Peter Tony, Eugen Feist, Peer Malte Aries, et al.
Page
of 2